Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lidija Sölkner"'
Autor:
Gudrun Piringer, Thomas Gruenberger, Josef Thaler, Irene Kührer, Klaus Kaczirek, Friedrich Längle, Istvan Viragos-Toth, Arno Amann, Wolfgang Eisterer, Reinhold Függer, Johannes Andel, Angelika Pichler, Judith Stift, Lidija Sölkner, Michael Gnant, Dietmar Öfner
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundTwenty percent of colorectal cancer liver metastases (CLMs) are initially resectable with a 5-year survival rate of 25%–40%. Perioperative folinic acid, 5-fluorouracil, oxaliplatin (FOLFOX) increases progression-free survival (PFS). In ad
Externí odkaz:
https://doaj.org/article/a086fc5f438c457e89f61feead205633
Autor:
Ana-Alicia Beltran-Bless, Mark J. Clemons, Christian Fesl, Richard Greil, Gregory R. Pond, Marija Balic, Lisa Vandermeer, Vesna Bjelic-Radisic, Christian F. Singer, Guenther G. Steger, Ruth Helfgott, Daniel Egle, Lidija Sölkner, Simon P. Gampenrieder, Stephanie Kacerovsky-Strobl, Christoph Suppan, Magdalena Ritter, Gabriel Rinnerthaler, Georg Pfeiler, Hannes Fohler, Dominik Hlauschek, John Hilton, Michael Gnant
Publikováno v:
European journal of cancer (Oxford, England : 1990). 180
The widespread adoption of adjuvant bisphosphonate therapy for postmenopausal early breast cancer (EBC) patients was based on results of the Early Breast Cancer Trialist Group (EBCTCG) meta-analysis. Despite multiple regimens evaluated, there was no
Autor:
Marija Balic, Dietmar Heck, Raimund Jakesz, E. Melbinger-Zeinitzer, Richard Greil, Karin S. Kapp, Felix Sedlmayer, Martina Metz, Herbert Stöger, Viktor Wette, Martin Wiesholzer, Gerd Fastner, Lidija Sölkner, Wilfried Horvath, Werner Kwasny, Ronald Zwrtek, Christian Fesl, Dagmar Semmler, Michael Gnant, Vesna Bjelic-Radisic, Joachim Widder, Ursula Wieder, Hans Geinitz
Publikováno v:
European Journal of Cancer. 127:12-20
To investigate long-term results of patients with hormonal receptor-positive breast cancer treated with breast-conserving surgery (BCS) and consecutive endocrine therapy (ET) with or without whole breast irradiation (WBI).Within the 8 A trial of the
Autor:
Michael Gnant, Hellmut Samonigg, Alexander de Vries, Gudrun Piringer, Richard Greil, Dietmar Öfner, Austrian Breast, Josef Thaler, J. Tschmelitsch, Wolfgang Eisterer, Lidija Sölkner
Publikováno v:
Anticancer Research. 37:2683-2691
Aim To evaluate feasibility and safety of neoadjuvant chemotherapy with capecitabine, oxaliplatin and bevacizumab followed by concomitant standard chemoradiation and surgical resection in patients with high-risk locally advanced rectal cancer. Patien